Searched for
NATCO SHARE PRICE
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...- Ahead of Market: 10 things that will decide stock market action on TuesdayBenchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent ...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Stock Radar: Natco Pharma stock shows rounding bottom formation; should you buy the stock for long term?Natco Pharma is trading above the neckline of a rounding bottom formation, suggesting a bullish outlook. Experts recommend buying for a tar...
- Natco Pharma shares drop over 5% after previous day’s double-digit gainsNatco Pharma shares fell as investors booked profits after a sharp rally in the previous session. The stock has been volatile this week, sl...
- Natco Pharma to acquire significant stake in S African firm Adcock IngramIndian pharmaceutical company Natco Pharma is set to acquire significant stakes in South Africa's Adcock Ingram, a 135-year-old firm, in a ...
- Stock Radar: Natco Pharma stock showing signs of momentum after falling over 30% from highs – what should investors do?Natco Pharma Ltd, a player in the pharma industry, has exhibited a bullish breakout from an Ascending Triangle pattern, hinting at potentia...
- NATCO Pharma shares plunge 20% after Q3 profit decline 37% YoY to Rs 132 croreNATCO Pharma faced a sharp decline, with a 37.75% drop in net profit in Q3 to Rs 132.4 crore due to lower formulation exports. Despite a ri...
- Accumulate Natco Pharma, target price Rs 1116: Geojit Financial ServicesNatco Pharma, incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 17460.53 crore) operating in pharmaceuticals s...
- Natco Pharma approves Rs 210 cr-share buyback; stock risesThe buyback proposal will not exceed the maximum size, which represents 5.13% and 5.04% of the aggregate of the total paid-up capital and f...
- Midcap pharma stock rises over 4% on share buyback planNatco Pharma has a market cap of Rs 10,367 crore as of March 3, 2023. From its 52-week high of Rs 920, the stock is trading 38% lower at Rs...
- Chart Check: 40% down from highs, this pharma stock showing signs of bottoming out; time to buy?The stock found support around Rs 502 earlier in February 2023 for the second time after March 2020 before recouping some losses. Most tech...
- Natco Pharma rises 4% on receiving court order to launch ChlorantraniliproleNatco is the first company in India to have received its registration approval given by the Central Insecticide Board & Registration Commit...
- Natco Pharma shares hit upper circuit. Here's whyThe Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.
- Natco Pharma soars 17% as path to launch Revlimid generic clearsNatco Pharma would be the first company to launch Revlimid (lenalidomide) in March 2022 as Dr Reddy’s settlement clears the path for the co...
- Buy Natco Pharma, target Rs 908: GeojitBuy Natco Pharma Ltd. at a price target of Rs 908.
Load More
